Results 101 to 110 of about 4,608 (205)

Uncovering cantharidin's mechanism for cholangiocarcinoma treatment using patient-derived tumor organoids. [PDF]

iScience
Han P, Wang L, Zhu L, Tong W, Liu S, Wang T, Yang T, Li Z, Zhou X, Zhao T, Cui T, Yang L, Wang Z, Zhang Y.   +13 more
europepmc   +1 more source

Processing-induced detoxification of toxic Traditional Chinese Medicines: a systematic review of attenuation mechanisms at physical, chemical, and in vivo levels. [PDF]

Chin Med
Zhang W, Zhang Z, Bian Z, Zuo Q, Quan X, Gong J, Ju B, Feng L, Jia X, Yang B.   +9 more
europepmc   +1 more source

Cantharidin Suppresses Cell Viability and Induces Apoptosis of SK-N-SH and SH-SY5Y Cells. [PDF]

In Vivo
Pei JS, Lee HT, Chen CC, Hsu PC, Chen JC, Hsia TC, Chang WS, Bau DT, Tsai CW.   +8 more
europepmc   +1 more source

Cantharidin attenuates the anti-β-adrenergic or anti-histaminergic or anti-serotoninergic effect of A₁-adenosine receptor stimulation in the isolated human atrium. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Schwarz R, Hofmann B, Kirchhefer U, Neumann J, Gergs U.   +4 more
europepmc   +1 more source

Correction: Glycyrrhetinic acid-modified redox-sensitive polymeric mixed micelles for tumor-specific intracellular delivery of cantharidin. [PDF]

RSC Adv
Hu Y, Lan T, Li J, Li L, Song J.
europepmc   +1 more source

Aptamer-Mediated Dual-Loaded Liposomal Nanosystem for Synergistic Therapy in Hepatocellular Carcinoma via mTOR/HIF-1α/VEGF Pathway. [PDF]

Int J Nanomedicine
Wei A, Zhong Z, Zhang Y, He J, Pang H, Xia X, Zhang X.   +6 more
europepmc   +1 more source

Dual-ligand-modified cantharidin nanoparticles for the treatment of hepatocellular carcinoma via the inhibition of Ephb4. [PDF]

Drug Deliv
Jiang W, Zheng H, Wang S, Xu R, Chen X, Yang J, Xia X.   +6 more
europepmc   +1 more source

Novel drug research and therapeutic strategies targeting tumor metastasis and cancer stem cells. [PDF]

Front Pharmacol
Xie S, Zhou Z, Zheng Y, Yu C, Kong W, Chen Y, Si W, Zhou F, Yang Z, Ni R, Chang C, Zhang Y.   +11 more
europepmc   +1 more source

Methyl-cantharidimide suppresses cyclin-dependent kinase 1 (CDK1) and induces oxeiptosis in liver cancer. [PDF]

J Exp Clin Cancer Res
Li YD, Chen X, Dong XD, Ding Z, Chen ZS, Fang S.   +5 more
europepmc   +1 more source

Network Pharmacology and Experimental Validation Reveal Aidi Injection Suppresses Prostate Cancer via EGFR Inhibition and STAT3-Mediated Apoptosis. [PDF]

Biol Proced Online
You G, Qian C, Chen X, An Q, Song J, Xiao Y.   +5 more
europepmc   +1 more source